2019 Vault Rankings
At a Glance
"Freedom to operate and encouragement to excel."
“Hours and burnout.”
“The pace can test your stamina.”
"Based on friends who work there, it seems Putnam's name is growing within healthcare consulting."
"Strong in healthcare."
"Heard about nice experiences from friends who work there; work-life balance seems to be very good among consulting firms."
About Putnam Associates
Over the last 30 years Putnam Associates has grown into a premier strategy consulting firm serving biopharmaceutical, biotechnology (cell, gene and tissue therapies), diagnostics, medical device, and related clients in the healthcare space. The firm provides objective, high impact strategic advice and analytical services, helping to support clients in crucial business decisions at all stages of the product and franchise lifecycle. Putnam's clients range from venture-backed biotechs (smallest client: 3-employee startup) to fortune 500 companies, including the majority of the world's major biopharmaceutical companies—indeed, despite being based in the US, more than half of Putnam's projects are global in focus. Putnam's commitment to client success has sustained many relationships that stretch back more than a decade and has enabled continued expansion into new client opportunities every year.
Putnam focuses solely on the life sciences, offering services focused on both development-stage and marketed products. That's good news for the firm's clients, who can spend more than 10 years developing new products—including wading through years of discovery, comprehensive testing, regulatory reviews, and commercialization prep—before the products even make it to market. Services include portfolio prioritization, market opportunity evaluations, competitive landscape assessments, product development strategies, in-licensing assessments, and growth strategies.
Committed to Long-Term Relationships
By providing insight and long-term support, Putnam has become the strategic partner of choice to a growing roster of clients. That long-term commitment also goes for the firm's employees—rather than being a landing spot for a year or two, the firm wants employees to see the potential for a longer-term career at Putnam. Accordingly, the firm provides both formal and informal mentorship, and cultivates an enriching professional culture. Over the last three years Putnam has significantly expanded its formal training and MBA tuition reimbursement programs encourage employees to continue learning. Firm knowledge development projects delve into the latest breakthroughs in areas like cell, gene, and tissue therapy leading to exciting new clients. The firm promotes community engagement and personal growth. Putnam sponsors a Summer Days of Service initiative driven by staff where Putnam teams volunteer their time and energy to support Boston and San Francisco area community organizations. Other initiatives include firm sponsored sports leagues and a consultant-organized monthly book club.
The firm's commitment to employee development is partly demonstrated by its MBA-admissions track record–since 2005, almost 2/3 of MBA-bound Putnams have attended Harvard Business School, MIT Sloan, UPenn Wharton, Northwestern, Stanford GSB, or INSEAD. Additionally, several recent MBA graduates have elected to take advantage of the firm's expanded tuition-reimbursement program and return to Putnam in managerial roles.
When Putnam's consultants do leave, the firm is committed to fostering the professional success of alumni, recently launching a program of alumni outreach and events that bring together a growing roster of former staff that have gone on to success in other biotech pursuits.
Ensuring a Successful Launch
Nearly half of Putnam's projects in the past year have addressed the challenges of bringing cutting edge medical innovations to market. The firm is currently supporting clients on the cutting edge in CAR-T cancer therapies, gene therapies, and stem cell therapies. In a typical recent project, Putnam helped validate the epidemiology of untreated patient populations, then worked with the client to better define unmet medical needs in the therapeutic area. This led to recommendations around endpoints in Phase III trial designs. Putnam then worked with the commercial team to build strategies around introducing the product to target markets. At the same time, Putnam helped build forecast models for key countries and conducted pipeline assessments to help the client keep abreast of fast moving clinical developments among competitors (which also informed in-licensing scans). Whether Putnam's clients are honing their portfolios, developing new products, or trying to grow marketed products, the firm's strength lies in its ability to consistently deliver exceptional work and superior insights on the industry's complex challenges.
Why Work Here
- At Putnam, we operate with a team-based approach that is client focused and impact oriented.
- Putnam is a specialist firm where employees are given the opportunity to excel.
- Putnam relies on the talent and motivation of our staff.
- Putnam Associates has built a close-knit and supportive culture.
501 Boylston Street
Boston, MA 02116
Phone: (617) 456-5200
Employer Type: Private
Partner, Boston Office Head: Matt Riordan
2018 Employees (All Locations): 124
Boston, MA (HQ)
San Francisco, CA
Portfolio, Licensing & Development Strategy
New Products Strategy
Established Product & Franchise Strategy
Pricing, Reimbursement, & Market Access
Other Strategic Projects